Megan Brooks

Women less likely to receive heart meds in primary care

May 21 2020

NEW YORK (Reuters Health) - There are clear gender differences in the medication prescribed in primary care to adults with or at high risk for heart disease, with women less apt than men to receive aspirin and statins, a new study indicates.

Interferon therapy may speed recovery from COVID-19

May 20 2020

NEW YORK (Reuters Health) - Treatment with the antiviral interferon alfa-2b (IFN-a2b) appears to speed up virus clearance and lower levels of key inflammatory markers in patients with COVID-19, according to an exploratory study conducted in Wuhan, China.

Medicaid expansion followed by bigger drop in cancer-related deaths

May 18 2020

NEW YORK (Reuters Health) - States that expanded Medicaid under the Affordable Care Act (ACA) saw greater declines in cancer-related deaths than states that did not, according to the first nationwide study of its kind.

Blood test improves early detection of multiple cancers

May 15 2020

NEW YORK (Reuters Health) - A blood test can detect multiple types of cancer in people with no history or symptoms of cancer and can be safely incorporated into routine clinical care to help guide patient management in real-time, leading to early treatment, new research indicates.

Immunotherapy improves outcome in high-risk, HER2-negative breast cancer

May 08 2020

NEW YORK (Reuters Health) - Adding the immune-checkpoint inhibitor durvalumab and the PARP inhibitor olaparib to standard neoadjuvant chemotherapy may improve outcome in women with high-risk, HER2-negative breast cancer, according to results of the I-SPY 2 trial.

Trial of intermittent dabrafenib/trametinib dosing for BRAF-mutated melanoma fails

May 06 2020

NEW YORK (Reuters Health) - A new study has dashed hopes that intermittent dosing of BRAF inhibitor dabrafenib and the MEK inhibitor trametinib would be as effective as continuous dosing of the drugs in patients with advanced BRAF-mutated melanoma.

Fecal transplant may benefit some patients with multidrug-resistant organisms

May 05 2020

NEW YORK (Reuters Health) - Chronically ill patients infected with multidrug-resistant organisms (MDROs) during extensive medical care for serious conditions may benefit from fecal microbiota transplantation (FMT), a pilot study suggests.

'Liquid' biopsy spots cancer early in tissue of origin

May 04 2020

NEW YORK (Reuters Health) - A blood test in development can detect cancer and tissue of origin with few false positives but many false negatives in people suspected of having cancer before a histologic diagnosis is made, according to a new study.

CloroCovid-19 trial of high-dose chloroquine halted early due to toxicity, deaths

Apr 27 2020

NEW YORK (Reuters Health) - The Brazilian CloroCovid-19 trial testing the safety and efficacy of a high dose of chloroquine in patients with severe COVID-19 has been terminated early after an interim analysis showed it was associated with more toxic effects and deaths, particularly affecting heart rhythms, than a lower dose.

Healthy diet cuts risk of dying from breast cancer in older women

May 16 2019

A balanced, low-fat diet significantly lowers the risk of dying from breast cancer in postmenopausal women, according to new long-term data from the Women's Health Initiative (WHI) Dietary Modification trial.

World News

ASEAN excludes Myanmar junta leader from summit in rare move

BANDAR SERI BEGAWAN (Reuters) -Southeast Asian countries will invite a non-political representative from Myanmar to a regional summit this month, delivering an unprecedented snub to the military leader who led a coup against an elected civilian government in February.